The global biosensors market is projected to grow from $28.8 billion in 2023 to $55.4 billion by 2032, with a CAGR of 7.3%. Biosensors are essential for diagnostics, disease detection, and environmental monitoring, as they convert biological signals into quantifiable outputs. Key factors driving this market include increased demand for point-of-care testing and the necessity for real-time health management.

1. Global Biosensors
Market Research and
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure
lasting results.

3. Report
Highlight and
Description
According to the latest report by IMARC Group, titled "Biosensors Market:
Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-
2032," the global biosensors market size reached US$ 28.8 Billion in 2023.
Biosensors are analytical devices that combine a biological component with a
transducer to detect and convert a biological signal into a quantifiable output.
They play a pivotal role in diagnostics, enabling the rapid and accurate detection
of various biomarkers. They aid in early detection of diseases, such as cancer
and infectious diseases, facilitating timely interventions.
They are also instrumental in assessing the quality of air, water, and soil by
detecting contaminants and pollutants. Furthermore, they can detect allergens,
pathogens, and spoilage indicators, ensuring the production of safe and high-
quality food products.
Request for a PDF sample of this report:
https://www.imarcgroup.com/biosensors-market/requestsample

4. Report Description
Global Biosensors Market Trends:
At present, the growing demand for biosensors to detect specific biomarkers and pathogens represents one of
the key factors offering a favorable market outlook. Biosensors also enable point-of-care (POC) testing, early
disease detection, and personalized medicine, making them indispensable in modern healthcare. In addition,
biosensors are essential tools for managing and monitoring chronic diseases, such as diabetes and
cardiovascular disorders conditions.
The ability of biosensors to provide real-time data empowers patients to take proactive measures in managing
their health, which is contributing to the growth of the market. Moreover, increasing environmental concerns are
leading to a growing need for monitoring and mitigating pollution. This, in turn, is catalyzing the demand for
biosensors, as their high sensitivity and specificity make them invaluable in assessing environmental quality.
Looking forward, the market value is projected to reach US$ 55.4 Billion by 2032, expanding at a CAGR of
7.3% during 2024-2032.
View Report TOC, Figures and Tables : https://www.imarcgroup.com/biosensors-market

5. Report
Segmentation
Breakup by Product:
• Wearable Biosensors
• Non-Wearable Biosensors
Breakup by Technology:
• Electrochemical Biosensors
• Optical Biosensors
• Piezoelectric Biosensors
• Thermal Biosensors
• Nanomechanical Biosensors
• Others
Breakup by Application:
• Blood Glucose Testing
• Cholesterol Testing
• Blood Gas Analysis
• Pregnancy Testing

6. Report
Segmentation
• Drug Discovery
• Infectious Disease Testing
• Others
Breakup by End Use:
• Point of Care Testing
• Home Healthcare Diagnostics
• Research Laboratories
• Security and Biodefense
• Others
Breakup by Region:
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7. Competitive
Landscape with
Key Players
• Abbott Laboratories
• AgaMatrix Inc. (WaveForm Technologies Inc)
• DuPont de Nemours Inc.
• F. Hoffmann-La Roche AG
• General Electric Company
• LifeScan Inc. (Platinum Equity LLC)
• Medtronic PLC
• Nova Biomedical Corporation
• PHC Holdings Corporation
• Siemens AG
• Thermo Fisher Scientific Inc.

8. Key Questions
Answered in
the Report
What was the size of the global biosensors market in 2023?
What is the expected growth rate of the global biosensors
market during 2024-2032?
What are the key factors driving the global biosensors
market?
What has been the impact of COVID-19 on the global
biosensors market?
What is the breakup of the global biosensors market
based on the product?
What is the breakup of the global biosensors market
based on the technology?

9. Key Questions
Answered in
the Report
What is the breakup of the global biosensors market
based on the application?
What is the breakup of the global biosensors market
based on the end use?
What are the key regions in the global biosensors market?
Who are the key players/companies in the global
biosensors market?

10. Table of
Contents
1 P r e f a c e
2 S c o p e a n d M e t h o d o l o g y
2 . 1 O b j e c t i v e s o f t h e S t u d y
2 . 2 S t a k e h o l d e r s
2 . 3 D a t a S o u r c e s
2 . 3 . 1 P r i m a r y S o u r c e s
2 . 3 . 2 S e c o n d a r y S o u r c e s
2 . 4 M a r k e t E s t i m a t i o n
2 . 4 . 1 B o t t o m - U p A p p r o a c h
2 . 4 . 2 To p - D o w n A p p r o a c h
2 . 5 F o r e c a s t i n g M e t h o d o l o g y
3 E x e c u t i v e S u m m a r y
4 I n t r o d u c t i o n
4 . 1 O v e r v i e w
4 . 2 K e y I n d u s t r y T r e n d s
5 G l o b a l B i o s e n s o r s M a r k e t
5 . 1 M a r k e t O v e r v i e w
5 . 2 M a r k e t P e r f o r m a n c e
5 . 3 I m p a c t o f C O V I D - 1 9
5 . 4 M a r k e t F o r e c a s t
6 M a r k e t B r e a k u p b y P r o d u c t
6 . 1 W e a r a b l e B i o s e n s o r s
6 . 1 . 1 M a r k e t T r e n d s
6 . 1 . 2 M a r k e t F o r e c a s t
6 . 2 N o n - W e a r a b l e B i o s e n s o r s
6 . 2 . 1 M a r k e t T r e n d s
6 . 2 . 2 M a r k e t F o r e c a s t
7 M a r k e t B r e a k u p b y T e c h n o l o g y
7 . 1 E l e c t r o c h e m i c a l B i o s e n s o r s
7 . 1 . 1 M a r k e t T r e n d s
7 . 1 . 2 M a r k e t F o r e c a s t

11. Table of
Contents
7 . 2 O pt i c a l B i o s e n s o r s
7 . 2 . 1 Ma r k e t Tr e n d s
7 . 2 . 2 Ma r k e t F o r e c a s t
7 . 3 Pi e z oe le c t r ic B io s e n s o r s
7 . 3 . 1 Ma r k e t Tr e n d s
7 . 3 . 2 Ma r k e t F o r e c a s t
7 . 4 T h er ma l B io s e n s o r s
7 . 4 . 1 Ma r k e t Tr e n d s
7 . 4 . 2 Ma r k e t F o r e c a s t
7 . 5 Na n o me c h a n i c a l B i o s e n s o r s
7 . 5 . 1 Ma r k e t Tr e n d s
7 . 5 . 2 Ma r k e t F o r e c a s t
7 . 6 O t h e r s
7 . 6 . 1 Ma r k e t Tr e n d s
7 . 6 . 2 Ma r k e t F o r e c a s t
8 Ma r k e t Br e a k u p b y A pp l i c a t i on
8 . 1 Bl o o d G lu c o s e Te s t i n g
8 . 1 . 1 Ma r k e t Tr e n d s
8 . 1 . 2 Ma r k e t F o r e c a s t
8 . 2 Ch o l e s t e r o l Te s t i n g
8 . 2 . 1 Ma r k e t Tr e n d s
8 . 2 . 2 Ma r k e t F o r e c a s t
8 . 3 Bl o o d G a s A n a l y s i s
8 . 3 . 1 Ma r k e t Tr e n d s
8 . 3 . 2 Ma r k e t F o r e c a s t
8 . 4 Pr e g n a n c y Te s t in g
8 . 4 . 1 Ma r k e t Tr e n d s
8 . 4 . 2 Ma r k e t F o r e c a s t
Fo r m o r e i nf o r m a t i o n , v i s i t :
h tt p s: / / w w w. i m arc gro u p . c o m / b i os e n s o r s- m ar ke t / t o c

12. Partial List of Clients

13. Partial List of Clients

14. Disclaimer
© 2024 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also
not be used in any form or by and means graphic electronic or mechanical, including photocopying,
recording, taping or by information storage or retrieval, or by any other form, without the express
consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion
have been based on information and sources believed to be accurate and reliable at the time of
publishing. International Market Analysis Research and Consulting makes no representation of
warranty of any kind as to the accuracy or completeness of any Information provided. IMARC
accepts no liability whatsoever for any loss or damage resulting from opinion, errors or
inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International
Market Analysis Research and Consulting. All other trademarks used in this publication are
registered trademarks of their respective companies.

15. Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
sales@imarcgroup.com
Stay With Us: